Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Berberine Sulfate
2. 316-41-6
3. Berberin Sulfate
4. Berberine Sulfate (2:1)
5. Berberal
6. Berberine Sulfate Trihydrate
7. Neutral Berberine Sulfate
8. 6190-33-6
9. Ai3-61947
10. Fst3e667ff
11. Berberine Sulfate Anhydrous
12. Erben
13. Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-, Sulfate (2:1)
14. 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium Sulfate
15. Berberine Sulfate (van)
16. Nsc-5355
17. Hsdb 2170
18. Nsc 5355
19. Einecs 206-258-2
20. Unii-fst3e667ff
21. Berberinsulfat
22. 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Hemisulfate
23. Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydr0-9,10-dimethoxy-, Sulfate (2:1)
24. Berbinium, 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)-, Sulfate (2:1)
25. Schembl94112
26. Berberine Sulfate [hsdb]
27. Dtxsid70977452
28. Berberine Sulfate [who-dd]
29. Akos024319280
30. 16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;sulfate
31. Bs-16855
32. B0451
33. Cs-0021605
34. D88653
35. Q27278174
36. 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium Sulphate
37. 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium Sulfate(2:1)
38. 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-iumsulfate(2:1)
39. Bis(9,10-dimethoxy-5,6-dihydro-2h-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium) Sulfate
| Molecular Weight | 768.8 g/mol |
|---|---|
| Molecular Formula | C40H36N2O12S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 4 |
| Exact Mass | 768.19889576 g/mol |
| Monoisotopic Mass | 768.19889576 g/mol |
| Topological Polar Surface Area | 170 Ų |
| Heavy Atom Count | 55 |
| Formal Charge | 0 |
| Complexity | 551 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
EXPTL USE (VET): ORALLY ADMIN BERBERINE SULFATE (350-700 MG/KG) WAS EFFECTIVE IN TREATING CANDIDA ALBICANS INFECTIONS OF THE INTESTINE IN MICE.
MIRSKA I ET AL; ARCH IMMUNOL THER EXP; 20(6) 921 (1972)
EXPTL USE: DILATION OF HUMAN EYE PUPILS, TOPICAL ANESTHESIA &/OR FLUORESCENT STAINING OF CORNEAL EPITHELIAL DEFECTS &/OR FLUORESCENCE IN APPLANATION TONOMETRY, IS ACCOMPLISHED BY TOPICAL APPLICATION OF OPHTHALMIC SOLN OF HYDRASTIS COMPD SUCH AS BERBERINE.
MEDOW NB, GRECO JJ; US PATENT NUMBER 3943251 03/09/76
/PRC: FORMER USES/ BITTER STOMACHIC; ANTIBACTERIAL; ANTIMALARIAL; ANTIPYRETIC /BERBERINE/
The Merck Index. 9th ed. Rahway, New Jersey: Merck & Co., Inc., 1976., p. 153
MILD LOCAL ANESTHETIC ON MUCOUS MEMBRANE. /BERBERINE/
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-161
...MAY BE ABSORBED THROUGH THE SKIN... /BERBERINE/
Sax, N.I. Dangerous Properties of Industrial Materials. 5th ed. New York: Van Nostrand Rheinhold, 1979., p. 412
Market Place
ABOUT THIS PAGE
A Berberine Sulphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Berberine Sulphate, including repackagers and relabelers. The FDA regulates Berberine Sulphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Berberine Sulphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Berberine Sulphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Berberine Sulphate supplier is an individual or a company that provides Berberine Sulphate active pharmaceutical ingredient (API) or Berberine Sulphate finished formulations upon request. The Berberine Sulphate suppliers may include Berberine Sulphate API manufacturers, exporters, distributors and traders.
click here to find a list of Berberine Sulphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Berberine Sulphate Drug Master File in Japan (Berberine Sulphate JDMF) empowers Berberine Sulphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Berberine Sulphate JDMF during the approval evaluation for pharmaceutical products. At the time of Berberine Sulphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Berberine Sulphate suppliers with JDMF on PharmaCompass.
Berberine Sulphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Berberine Sulphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Berberine Sulphate GMP manufacturer or Berberine Sulphate GMP API supplier for your needs.
A Berberine Sulphate CoA (Certificate of Analysis) is a formal document that attests to Berberine Sulphate's compliance with Berberine Sulphate specifications and serves as a tool for batch-level quality control.
Berberine Sulphate CoA mostly includes findings from lab analyses of a specific batch. For each Berberine Sulphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Berberine Sulphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Berberine Sulphate EP), Berberine Sulphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Berberine Sulphate USP).
LOOKING FOR A SUPPLIER?
